Clinical Trial Update: Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF) [Phase 1]

View source ↗

Summary

A Phase 1 trial of JK07 in heart failure with reduced ejection fraction has completed enrollment and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• JK07

Snippet

Sponsor: Salubris Biotherapeutics Inc | Conditions: Heart Failure With Reduced Ejection Fraction | Phase 1 | Status: COMPLETED | Results posted: 2025-07-09